Surgery to remove pituitary tumors, the first-line treatment for Cushing’s disease, can increase the risk of venous thromboembolism (VTE), or blood clot formation in veins, especially within a week of the procedure, according to a new study. Identified risk factors for post-surgical VTE include older age, high blood pressure,…
News
Low-dose aspirin, an antiplatelet agent used to reduce blood clotting, may be better than enoxaparin, the current gold standard, at preventing thromboses in people with Cushing’s syndrome, a U.S. study found. Compared with those on enoxaparin, a form of low-molecular weight heparin (LMWH), patients who took low-dose aspirin had a…
Ectopic Cushing’s syndrome can have different outcomes depending on tumor type, with about 8 in 10 people with lung tumors and 4 in 10 with pancreatic tumors remaining alive five years after diagnosis, according to a meta-analysis study by researchers in Sweden. Patients lived longer when the tumor could…
A test that uses the hormone-release stimulant desmopressin to trace the source of excess adrenocorticotropic hormone (ACTH) helped correctly diagnose Cushing’s disease in four children, but was less reliable in precisely locating the disease-causing tumor, according to a report from Iran. Desmopressin could be a “cost-effective alternative” to…
An imaging technique developed by scientists in India may help clinicians accurately identify tumors associated with Cushing’s disease, including in cases that are difficult to diagnose with other methods, a study reports. This new method uses a novel form of positron emission tomography (PET) imaging alongside CT scans to…
A U.S. case study describes woman in remission from Cushing’s disease who later developed a different form of Cushing’s syndrome, a rare occurrence that researchers said suggests the need for recognizing that this may happen and adopting individualized treatment approaches. The woman was initially diagnosed with Cushing’s disease, a…
People with adrenal Cushing’s syndrome who were diagnosed in the 2000s often had the condition identified incidentally — but also experience fewer symptoms specific to Cushing’s compared with individuals receiving a diagnosis in previous decades, a study in Japan has found. However, the prevalence of Cushing’s-related complications, including cardiovascular events…
Treatment with Isturisa (osilodrostat) was found to be effective for reducing cortisol levels in people with Cushing’s disease and other forms of Cushing’s syndrome, according to data from a real-world study. The study, “Osilodrostat Treatment of Cushing Syndrome in Real-World Clinical Practice: Findings From the…
Measuring cortisol in a small sample of saliva collected late at night may work just as well as the 24-hour urine test — which involves collecting urine passed during the day and night — for checking whether Cushing’s disease is in remission after radiotherapy, a study by U.S. researchers…
Individualized treatments helped two women and their babies avoid complications of Cushing’s syndrome during pregnancy, according to a case report. “Careful clinical observation during pregnancy and after delivery is necessary to initiate appropriate treatment,” the researchers wrote. Both cases were detailed in the study, “Diagnosis and Management…
Recent Posts
- Study supports Isturisa as first-line ectopic Cushing’s treatment
- After some scary complications, I finally gave birth to a baby girl
- Rare dual diagnosis explains man’s chronic high blood pressure: Report
- Woman with recurrent Cushing’s disease has 2 successful pregnancies
- Real-world study backs Isturisa for non-pituitary Cushing’s forms
- New research shows Cushing’s adds hidden fat BMI may overlook
- Isturisa exposure early in pregnancy may be less risky than thought
- Alternative neck access allows doctors to complete key test
- A pregnancy complication leads to yet another hospital admission
- Cushing’s patient’s psychiatric shifts tied to rapid Isturisa dose increase